Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transient receptor potential channel 2 (TRP-2), also known as TRPC2, is a non-selective cation channel belonging to the canonical (TRPC) subfamily of the transient receptor potential (TRP) superfamily [1, 13]. While TRPC2 is a pseudogene in humans and Old World monkeys, it is a functional and essential channel in many other organisms, including rodents and parasitic nematodes [11, 16]. In rodents, it is primarily expressed in the vomeronasal organ and is crucial for pheromone-mediated social and sexual behaviors [17]. In filarial nematodes such as Brugia malayi, TRP-2 is expressed in the body wall muscle and has been identified as the direct molecular target of the anthelmintic drug diethylcarbamazine (DEC) [2, 4, 6]. DEC acts as an agonist of the TRP-2 channel, triggering a rapid influx of calcium ions that leads to muscle contraction and spastic paralysis of the parasite [8, 9]. This mechanism facilitates the clearance of microfilariae by the host's immune system, making TRP-2 a significant target for the treatment of lymphatic filariasis and loiasis [7, 10]. It is important to distinguish this ion channel from Tyrosinase-related protein 2 (also called TRP-2), which is an enzyme involved in melanin synthesis and a target in melanoma immunotherapy [14, 15].
Agonist activation of the channel leading to rapid calcium influx and spastic paralysis in parasitic nematodes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient receptor potential cation channel subfamily C member 2 (TRPC2) (TRPC2).